3 reasons why Enzyme Finance (MLN) is up 92% in a week
Enzyme price doubles in a week after major exchange listings and big-name DeFi partnerships lead to a 2,000% increase in 24-hour trading volume. Decentralized finance (DeFi) has emerged as one of the most promising real-world applications of blockchain technology, capable of reshaping the face of the global financial markets and transforming the way the average person manages their money. One DeFi focused project that has been gaining attention over the past week as the mainstream world slowly opens itself to the possibilities of DeFi is Enzyme Finance (MLN), a protocol focused on on-chain....
Related News
A rapidly growing ecosystem and recent Coinbase listings helped SOL and MLN bounce back from recent lows while the wider market trades sideways. Significant price corrections like the one see in May inflict widespread pain for a majority of market participants and can be a death sentence for struggling projects as token holders capitulate and dump their holdings for any price offered. While these periods are useful to help shakeout the weak hands and weed out unnecessary projects, they also offer strong performers the opportunity to stand out from the crowd and attract the attention of....
The growing need for data privacy and a renewed interest in the DeFi sector back the strong rallies seen in Dent, Arweave and Enzyme. According to a report by Coinshares, as of March 20, the weekly inflows into institutional crypto products has declined by about 59% when compared to the previous week. This suggests that institutional investors are taking a cautious approach after the recent bull run. However, that does not mean the institutional investors are dumping their holdings just yet. The report highlights that the total crypto investment products assets under management hit a new....
To demonstrate the use case and commercial viability of Unido Enterprise Platform (EP), it is helpful to compare with an established digital asset management platform which has built in DeFi options. Enzyme (MLN) has been selected for competitor comparison and analysis, given it launched in July 2016 and provides similar services and features as EP, albeit delivered in very different formats. Enzyme is delivered in two parts, a front end website for asset management and an Ethereum-native blockchain protocol to deploy custom liquidity pools, allowing investors to deploy their digital....
Crypto friendly regulations, rising user activity and a recent collaboration with Yearn finance back Curve DAO Token’s recent triple-digit rally. Over the past two weeks the entire DeFi sector has been in a strong uptrend and many of the top market cap tokens rallied by double and triple-digits.Curve DAO’s governance token CRV has been a standout performer, coming off a low at $0.54 on Jan. 11 to a 2021 high at $1.78 on Jan. 17. CRV/USDT 4-hour chart. Source: TradingviewThree reasons for this latest surge in volume and price for CRV are a new collaboration with the Yearn.finance (YFI)....
Investors include Lemniscap, P2P capital and others. Unslashed Finance has sold $400 million in coverage since its private launch last month. Unslashed Finance, a decentralized insurance protocol built on Ethereum, has raised $2 million to fund its tokenized insurance product, highlighting another positive use case for blockchain technology. The funding round, which was led by Lemniscap, P2P Capital and other investors, will aid Unslashed Finance in expanding its decentralized insurance protocol for crypto assets. The protocol works by connecting people willing to buy insurance for their....